Clinical Trial Update: DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial reports that inhibition of DPP-4 enzymes may promote healing of chronic foot ulcers in people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Chronic Foot Ulcers | Phase 4 | Status: COMPLETED | Results posted: 2015-06-04